ad

320 Crore Quarterly Profit Stocks to Buy in November 2026: 5 Names on the Watchlist

Ajanta Pharma Rs 3,284. Kalpataru Projects Rs 1,350. Max Healthcare Rs 947.10. Uno Minda Rs 1,388. NTPC Green Rs 82.97. NSE closing prices, 13 Nov 2026.


16 Nov 2026 • 2:41 pm

320 Crore Quarterly Profit Stocks to Buy in November 2026: 5 Names on the Watchlist

Quick Answer

Five 320 crore quarterly profit stocks to buy on the November 2026 watchlist are Ajanta Pharma, Kalpataru Projects International, Max Healthcare Institute, Uno Minda and NTPC Green Energy. All five grew revenue in their latest full year, and all five also grew net profit. Kalpataru Projects International has the lowest P/E at 20.12, while Ajanta Pharma leads on return on equity at 23.33%. Check each valuation against your own risk appetite before acting.

The 320 crore quarterly profit stocks to buy in November 2026 start with five listed names: Ajanta Pharma, Kalpataru Projects International, Max Healthcare Institute, Uno Minda and NTPC Green Energy. These five companies each earned between about Rs 305 crore and Rs 334 crore in net profit in the latest reported quarter.

This article ranks none of them as a sure thing. It lays out the numbers each company has reported, how the shares are priced today and what an investor should check before adding any of these 320 crore quarterly profit stocks to buy to a portfolio. All prices are NSE closing prices of 13 November 2026, and financials come from company filings.

Click Here – Get Free Investment Predictions

Which Are the Best 320 Crore Quarterly Profit Stocks to Buy in November 2026?

The best 320 crore quarterly profit stocks to buy in November 2026 for a watchlist are Ajanta Pharma, Kalpataru Projects International, Max Healthcare Institute, Uno Minda and NTPC Green Energy. They were picked because each has complete reported financials, profit in the latest quarter and an NSE listing. The table puts their market data side by side.

Company CMP (Rs) Market Cap P/E ROE Dividend Yield
Ajanta Pharma 3,284 Rs 43,234 crore 38.10 23.33% 0.81%
Kalpataru Projects International 1,350 Rs 22,710 crore 20.12 13.37% 0.83%
Max Healthcare Institute 947.10 Rs 82,873 crore 56.88 13.42% 0.23%
Uno Minda 1,388 Rs 63,290 crore 49.04 17.53% 0.24%
NTPC Green Energy 82.97 Rs 70,722 crore 116.57 2.76% 0.00%

On valuation, Ajanta Pharma, Kalpataru Projects International and Max Healthcare Institute sit close to it; Uno Minda and NTPC Green Energy carry a premium. Valuation is the first filter for any 320 crore quarterly profit stocks to buy list, and it is covered again in the risk section.

Why These 320 Crore Quarterly Profit Stocks to Buy Are in Focus

In this list, FY26 net profit and revenue both grew for every company, and quarterly profit in the latest reported quarter was higher than a year earlier for all five. The list covers a maker of pharma formulations, an engineering and construction company focused on power transmission, a hospital chain, an auto components maker and a renewable power producer. Investors comparing the best 320 crore quarterly profit stocks in India usually check earnings growth, dividends and how the shares are valued.

Ajanta Pharma: The Branded Generics Specialist Among 320 Crore Quarterly Profit Stocks to Buy

Ajanta Pharma is a branded generics company with a strong presence in dermatology, ophthalmology and cardiology in India, Africa and Asia. At Rs 3,284, the stock has a market capitalisation of Rs 43,234 crore and trades at 38.10 times earnings, while the industry P/E is 37.65.

Reported numbers show FY26 revenue of Rs 5,625 crore, up 18.6% year on year, with net profit at Rs 1,056 crore, up 14.7%. The June 2026 quarter added revenue of Rs 1,697 crore (up 27.7%) and net profit of Rs 334 crore (up 30.9%).

Return on equity is 23.33%, debt-to-equity is 0.06, and the dividend yield is 0.81%. Promoters hold 63.47%, foreign institutions 7.63% and domestic institutions 21.94% as of September 2026. Domestic institutional holding has risen from 17.90% to 21.94% over the last year.

Kalpataru Projects International: The Transmission and EPC Specialist Among 320 Crore Quarterly Profit Stocks to Buy

Kalpataru Projects International is an engineering, procurement and construction company working on power transmission, railways, water and buildings in India and abroad. Its market capitalisation is Rs 22,710 crore, the share price is Rs 1,350 and the P/E of 20.12 compares with an industry P/E of 21.53.

Over FY26, net profit rose 81.7% to Rs 1,031 crore on revenue of Rs 27,248 crore, which was up 21.8%. The latest quarter, the June 2026 quarter, brought revenue of Rs 6,485 crore, up 4.8% year on year, and net profit of Rs 312 crore, up 45.9%.

Return on equity is 13.37%, debt-to-equity is 0.46, and the dividend yield is 0.83%. Promoters hold 33.58%, foreign institutions 10.75% and domestic institutions 44.85% as of September 2026.

Check 320 Crore Quarterly Profit Stocks Live on the Univest Screener

Max Healthcare Institute: The Premium Hospital Network Among 320 Crore Quarterly Profit Stocks to Buy

Max Healthcare Institute is a premium hospital network with large facilities in north and west India. The stock trades at Rs 947.10 with a market capitalisation of Rs 82,873 crore and a P/E of 56.88, against an industry P/E of 61.50.

FY26 revenue rose 18.8% to Rs 8,536 crore and net profit rose 34.1% to Rs 1,442 crore. In the June 2026 quarter, revenue grew 16.6% year on year to Rs 2,407 crore, while net profit grew 4.9% to Rs 323 crore.

Return on equity is 13.42%, debt-to-equity is 0.32, and the dividend yield is 0.23%. Promoters hold 23.71%, foreign institutions 40.52% and domestic institutions 31.00% as of September 2026. Domestic institutional holding has risen from 20.03% to 31.00% over the last year.

Uno Minda: The Component Supplier Among 320 Crore Quarterly Profit Stocks to Buy

Uno Minda is a component supplier with electronics and EV-related products. At Rs 1,388, the stock has a market capitalisation of Rs 63,290 crore and trades at 49.04 times earnings, while the industry P/E is 36.13.

Reported numbers show FY26 revenue of Rs 19,692 crore, up 17.2% year on year, with net profit at Rs 1,284 crore, up 25.8%. The June 2026 quarter added revenue of Rs 5,563 crore (up 23.6%) and net profit of Rs 316 crore (up 2.1%).

Return on equity is 17.53%, debt-to-equity is 0.40, and the dividend yield is 0.24%. Promoters hold 68.36%, foreign institutions 8.78% and domestic institutions 17.11% as of September 2026. Domestic institutional holding has risen from 15.80% to 17.11% over the last year.

NTPC Green Energy: The Green Power Arm of NTPC Among 320 Crore Quarterly Profit Stocks to Buy

NTPC Green Energy is the renewable energy arm of NTPC, building solar and wind capacity. Its market capitalisation is Rs 70,722 crore, the share price is Rs 82.97 and the P/E of 116.57 compares with an industry P/E of 19.93.

Over FY26, net profit rose 10.0% to Rs 521 crore on revenue of Rs 3,035 crore, which was up 23.1%. The latest quarter, the June 2026 quarter, brought revenue of Rs 1,122 crore, up 49.2% year on year, and net profit of Rs 305 crore, up 38.3%.

Return on equity is 2.76%, debt-to-equity is 1.67, and the dividend yield is negligible. Promoters hold 89.01%, foreign institutions 1.58% and domestic institutions 5.29% as of September 2026. A point to keep in view: at a P/E of 116.57, expectations are already high, and debt is higher than most names on this list.

Download the Univest iOS App or Univest Android App to track these 320 crore quarterly profit stocks live and get daily stock recommendations.

Growth Snapshot: Latest Full Year and Latest Quarter

The table compares year-on-year growth in revenue and net profit for all five 320 crore quarterly profit stocks, using filed results.

Company Full-Year Revenue Growth Full-Year Profit Growth Latest Quarter Quarter Revenue Growth Quarter Profit Growth
Ajanta Pharma 18.6% 14.7% Jun 2026 27.7% 30.9%
Kalpataru Projects International 21.8% 81.7% Jun 2026 4.8% 45.9%
Max Healthcare Institute 18.8% 34.1% Jun 2026 16.6% 4.9%
Uno Minda 17.2% 25.8% Jun 2026 23.6% 2.1%
NTPC Green Energy 23.1% 10.0% Jun 2026 49.2% 38.3%

Factors That Move 320 Crore Quarterly Profit Stocks to Buy

Four factors tend to drive 320 crore quarterly profit stocks, and each one is worth checking before a purchase.

  • Quarterly profit: Each earned above Rs 300 crore in its latest reported quarter.
  • Dividends: Kalpataru Projects International yields about 0.8%.
  • Return on equity: Ajanta Pharma leads at about 23%.
  • Valuation: P/E runs from about 20 to 117.

Risks to Keep in Mind Before Buying 320 Crore Quarterly Profit Stocks

The first risk is that NTPC Green Energy trades at a P/E near 117, Max Healthcare Institute near 57 and Uno Minda near 49, while Kalpataru Projects International trades near 20, so expectations differ widely. The second is that NTPC Green Energy carries the highest borrowings of the five and power projects depend on timely execution. Check results every quarter.

On the numbers, NTPC Green Energy trades at the highest P/E on this list at 116.57, so its earnings need to keep growing to support the price. 320 Crore Quarterly Profit stocks to buy can still fall when markets turn weak, and a staggered entry has historically suited investors better than a lump-sum purchase.

How to Choose 320 Crore Quarterly Profit Stocks to Buy

  • Compare growth: Kalpataru Projects International grew FY26 profit most, by about 82%.
  • Check P/E: Kalpataru Projects International trades lowest.
  • Read the yield: Kalpataru Projects International pays the most.
  • Spread sectors: Mix pharma, engineering, hospitals, auto parts and renewable power.

How to Invest in 320 Crore Quarterly Profit Stocks

  1. Shortlist two or three companies from this list that match your risk appetite.
  2. Open the Univest Screener and compare P/E, ROE and debt for each stock.
  3. Check the latest quarterly results and shareholding pattern on NSE or BSE.
  4. Decide an amount you can hold for three to five years and split it into two or three purchases.
  5. Review the holding after every quarterly result instead of reacting to daily price moves.

Conclusion

Kalpataru Projects International offers the lowest P/E on this list at 20.12, Ajanta Pharma has the highest return on equity at 23.33%, and Kalpataru Projects International posted the fastest net profit growth in its latest full year at 81.7%. Among the best 320 crore quarterly profit stocks in India, these five give investors a spread of size, valuation and growth, so the right pick depends on risk appetite and holding period. Spread the entry, keep position sizes sensible and consult a SEBI-registered advisor before investing in any of these 320 crore quarterly profit stocks to buy.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on 320 Crore Quarterly Profit Stocks to Buy

Which are the best 320 crore quarterly profit stocks to buy in November 2026?

Ans. The five 320 crore quarterly profit stocks on the November 2026 watchlist are Ajanta Pharma, Kalpataru Projects International, Max Healthcare Institute, Uno Minda and NTPC Green Energy. Kalpataru Projects International has the lowest P/E at 20.12, Ajanta Pharma has the highest ROE at 23.33%, and Kalpataru Projects International grew net profit 81.7% in its latest full year. This is educational content, not investment advice, so please consult a SEBI-registered advisor.

Is Max Healthcare Institute a good stock to buy from this 320 Crore Quarterly Profit list?

Ans. Max Healthcare Institute is the largest company on this list with a market capitalisation of Rs 82,873 crore and a P/E of 56.88 against an industry P/E of 61.50. Its FY26 revenue rose 18.8% and net profit rose 34.1%, with return on equity at 13.42%. Whether it suits you depends on your risk appetite and holding period, so please consult a SEBI-registered advisor before investing.

Are these 320 crore quarterly profit stocks expensive right now?

Ans. Valuations vary across the group. Ajanta Pharma trades at a P/E of 38.10, Kalpataru Projects International trades at a P/E of 20.12, Max Healthcare Institute trades at a P/E of 56.88, Uno Minda trades at a P/E of 49.04, NTPC Green Energy trades at a P/E of 116.57, against industry multiples ranging from 19.93 to 61.50. Higher multiples reflect faster growth but also leave less room for earnings misses, so entry price deserves attention.

Which of these 320 crore quarterly profit stocks pay a dividend?

Ans. Dividend yields on this list are Ajanta Pharma 0.81%, Kalpataru Projects International 0.83%, Max Healthcare Institute 0.23%, Uno Minda 0.24%. Yields are modest across the group, so most investors look at these stocks for growth in earnings rather than for income, and payouts can change with company profits.

Which stock on this list has the highest return on equity?

Ans. Ajanta Pharma has the highest ROE on this list at 23.33%, followed by Uno Minda at 17.53% and Max Healthcare Institute at 13.42%. A higher ROE shows a company earns more profit on shareholder capital, but it should be read alongside valuation and debt.

What are the risks of investing in 320 crore quarterly profit stocks?

Ans. The main risks are very high valuations at three names, borrowings at the power producer and project execution timing. On this list, NTPC Green Energy trades at the highest P/E of 116.57, which leaves less room for earnings disappointments. Staggered buying and a long holding period can help manage these risks.

How can I invest in 320 crore quarterly profit stocks in India?

Ans. You can buy these stocks directly on NSE or BSE through a demat account, and compare them first on the Univest Screener using P/E, ROE and debt. Many investors split the amount across two or three purchases and review the holding after each quarterly result. Sector-themed mutual funds and ETFs are another route for investors who prefer diversification.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down